Female participants showed slightly higher nausea rates (31% versus 24%), which is consistent with whats observed across other GLP-1 class compounds
View Study [2]"Safety, tolerability, pharmacokinetics, and pharmacodynamics of cagrilintide with semaglutide" Enebo LB et al., 2021 Finding: Phase 1b trial demonstrated that combining cagrilintide with semaglutide 2.4mg resulted in up to 17.1% weight loss at 20 weeks, with the combination being well-tolerated
That said, long-term use isnt the right path for everyoneand with the right support, some patients successfully taper off and maintain results through lifestyle strategies and ongoing care
Our team is available to: GLP-1 Nutritional Assessment Customized protocol Selection of suitable supplements Regular monitoring Together, let's reactivate your natural GLP-1 for restored health
And the Glucose 6 Phosphate becomes 6 Phosphogluconate
W.PangL